Cargando…
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
Breast cancer is the most frequent cancer and the leading cause of cancer death in women. Oxidative stress and the generation of reactive oxygen species (ROS) have been related to cancer progression. Compared to their normal counterparts, tumor cells show higher ROS levels and tight regulation of RE...
Autores principales: | Griñan-Lison, Carmen, Blaya-Cánovas, Jose L., López-Tejada, Araceli, Ávalos-Moreno, Marta, Navarro-Ocón, Alba, Cara, Francisca E., González-González, Adrián, Lorente, Jose A., Marchal, Juan A., Granados-Principal, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911462/ https://www.ncbi.nlm.nih.gov/pubmed/33572626 http://dx.doi.org/10.3390/antiox10020205 |
Ejemplares similares
-
TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression
por: López-Tejada, Araceli, et al.
Publicado: (2023) -
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
por: Navarro-Ocón, Alba, et al.
Publicado: (2022) -
Drug Repurposing for Triple-Negative Breast Cancer
por: Ávalos-Moreno, Marta, et al.
Publicado: (2020) -
Are we there yet?
por: Wise, Jo Ann
Publicado: (2015) -
Are we there yet?
por: Swann, Nicole
Publicado: (2019)